This startup develops consumer products that utilize molecular and biological science to enhance healthspan and wellbeing through preventative health solutions. By providing accessible and effective tools, the company empowers individuals to take control of their health and longevity.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals struggle with persistent food cravings and suboptimal metabolic health, leading to challenges in achieving and maintaining a healthy weight. Existing weight management solutions often lack sustained efficacy or rely on methods that disrupt natural bodily functions.
Solution
Evolv offers an oral supplement designed to biomimetically activate the body's natural GLP-1 hormone pathways, supporting appetite regulation and metabolic health. The proprietary yeast strain, EV1 Peptide, is formulated to mimic GLP-1's effects, promoting satiety and reducing food cravings without disruptive side effects. This approach aims to facilitate sustainable weight management and enhance overall well-being by working in concert with the body's existing biological systems.
Target Audience
The primary target audience includes individuals seeking to support weight loss, manage appetite, improve metabolic function, and enhance overall well-being through a science-backed, natural supplement.
Features
- Oral supplement featuring a proprietary yeast strain (EV1 Peptide) designed to biomimetically activate GLP-1 receptors.
- Supports appetite regulation by promoting a feeling of fullness and reducing food cravings.
- Aids in metabolic health by supporting healthy blood sugar levels and efficient energy utilization.
- Formulated with natural ingredients including rice flour and bamboo stem/leaf extract for capsule consistency and digestive support.
- Clinically studied ingredient with reported outcomes including significant weight loss, waist reduction, and reduced daily caloric intake in third-party clinical testing.
- Differentiated from traditional supplements by its focus on sustained metabolic pathway activation rather than short-term thermogenic effects.
- Manufactured in a cGMP compliant facility in the USA.